We are honored to be associated with the USACFA. The work they do for the cystic fibrosis community – especially by providing a forum for an exchange of ideas – is truly inspiring.
Allentown, Pennsylvania (PRWEB) August 21, 2012
The United States Adult Cystic Fibrosis Association, Inc. (USACFA) recognizes PMD Healthcare as a Gold Benefactor in an upcoming issue of its journal CF Roundtable. PMD Healthcare manufactures Spiro PD, the world’s first and only personal spirometer.
For over 20 years as a non-profit organization, USACFA has provided education and support to adults who have cystic fibrosis as well as to their family members and caregivers.
Recently, USACFA President Laura Tillman participated in a Spiro PD webinar entitled Making Every Birthday Count. To listen to the webinar, visit http://spiropd.com/get-more-information/.
As the world’s first personal spirometer, Spiro PD empowers people with lung diseases – cystic fibrosis (CF), asthma, chronic obstructive pulmonary disease (COPD), bronchitis, emphysema, and lung transplants – to easily and accurately monitor their breathing any time and anywhere: at home, at work, at school, at play, or while traveling.
Helping patients monitor and prevent breathing problems can reduce expensive emergency room visits and hospital stays. In addition, Spiro PD enhances medication adherence by enabling people to manage their medications, view medication history, and set alarms reminding them when to take medicine. Plus, Spiro PD allows patients to quickly upload their data to share with their doctor.
Says Wayne Meng, Founder, Chief Executive Officer, and President of PMD Healthcare, “We are honored to be associated with the USACFA. The work they do for the cystic fibrosis community – especially by providing a forum for an exchange of ideas – is truly inspiring.”
For more information about all the advantages that Spiro PD offers people with lung disease, please visit http://www.spiropd.com.
About Spiro PD
Spiro PD ("Spiro" stands for spirometer, a device used to measure air entering and leaving the lungs; "PD" stands for personal device) is the first personal spirometer that enables people with lung diseases – asthma, COPD, CF, and lung transplants – to easily and accurately monitor their breathing anytime and anywhere. Spiro PD allows individuals to view their lung function trends over time, manage medications, set alarms reminding them to take medicine, do breathing exercises, and quickly upload data to their computer and share it with their doctor.
Spiro PD is cleared by the FDA for use by the patient to test lung function in children, adolescents, and adults. Spiro PD is certified with the CE mark for the European Union (EU). Spiro PD also meets American Thoracic Society (ATS) and European Respiratory Society (ERS) standards.
Spiro PD is available online with a prescription. For more information visit http://www.spiropd.com.
About PMD Healthcare, Inc.
PMD Healthcare, manufacturer of Spiro PD, is dedicated to creating innovative, easy-to-use, portable, and affordable personal medical devices that empower people worldwide to improve their healthcare and quality of life. For more information about PMD Healthcare and Spiro PD, please visit http://www.spiropd.com.